¶ National Institute of Allergy and Infectious Diseases
.png)
This page has moved! Click here to view the most up-to-date version of this page on the White Rose Wiki.
The National Institute of Allergy and Infectious Diseases (NIAID) is an agency of the United States Federal Government, one of the 27 institutes and centers that make up the National Institutes of Health (NIH).
¶ COVID-19
At least two NIAID employees participated in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, including Clint Florence and Judith Hewitt.[1]
¶ Vaccine development
NIAID holds patent rights to a modified version of the SARS-CoV-2 spike protein, which have been licensed for use in currently available COVID-19 vaccines including mRNA-1273 and BNT162b2.[2] The associated patents are:[3][4]
- Prefusion Coronavirus Spike Proteins and Their Use
- 62/972,886
- PCT/US2021/017709
- US Application 17/798,021
The inventors listed on these patents within NIAID are financial beneficiaries of their use, presenting a conflict of interest between NIAID and pharmaceutical companies including Moderna and Pfizer.[5]
In May 2022, NIAID licensed various COVID-19-related technologies to the World Health Organization's COVID-19 Technology Access Pool (C-TAP).[6][7]
¶ Organization
| Name | Position | Notes |
|---|---|---|
| Anthony Fauci | Director (1984-2022)[8] | - |
| Dean Follmann | Chief, Biostatistics Research Branch[9] | Center for Naval Analyses (CNA), National Heart, Lung and Blood Institute (NHLBI), American Statistical Association, Food and Drug Administration (FDA) |
¶ Subsidiaries
¶ Affiliations
NIAID has provided notable funding to:
- AMR One Health Consortium[10]
- Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)[11]
- Coronavirus Immunotherapy Consortium (CoVIC)[12]
¶ Publications
NIAID Biodefense Research Agenda for CDC Category A Agents
¶ External links
Preclinical Working Group. (2022, March 8). National Institutes of Health (NIH). http://archive.today/2022.04.02-062343/https://www.nih.gov/research-training/medical-research-initiatives/activ/preclinical-working-group ↩︎
Rizvi, Z. (2020, June 25). The NIH Vaccine. Public Citizen. http://archive.today/2021.01.01-104304/https://www.citizen.org/article/the-nih-vaccine/ ↩︎
Petrik, A. (2022, April 28). Prefusion Coronavirus Spike Proteins and Their Use. NIH Technology Transfer. https://web.archive.org/web/20230301012116/https://www.techtransfer.nih.gov/tech/tab-3532 ↩︎
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367(6483), 1260–1263. https://doi.org/10.1126/science.abb2507 ↩︎
COVID-19 Vaccines: Dr. Fauci’s Team May Personally Profit. (2020, October 11). ICAN - Informed Consent Action Network. http://archive.today/2023.03.01-015445/https://icandecide.org/article/covid-19-vaccines-dr-faucis-team-may-personally-profit/ ↩︎
NIH Contributions to WHO COVID-19 Technology Access Pool and Q&As | Technology Transfer. (2022, May 12). National Institutes of Health. https://web.archive.org/web/20230301014813/https://www.techtransfer.nih.gov/policy/ctap ↩︎
US NIH licenses to C-TAP. World Health Organization. Retrieved March 1, 2023, from https://web.archive.org/web/20230301024934/https://www.who.int/initiatives/covid-19-technology-access-pool/us-nih-licenses ↩︎
Previous Directors. NIH: National Institute of Allergy and Infectious Diseases. Retrieved August 22, 2023, from https://web.archive.org/web/20230822173840/https://www.niaid.nih.gov/about/directors ↩︎
Dean Follmann, Ph.D. (2017, May 10). National Institute of Allergy and Infectious Diseases. http://archive.today/2023.12.01-053526/https://www.niaid.nih.gov/about/brb-staff-follmann ↩︎
Funders. (2022). Research at UCalgary. http://archive.today/2022.06.07-225624/https://research.ucalgary.ca/amr/about-us/funders ↩︎
Funding Partners. (2022). CARB-X. http://archive.today/2022.06.06-075157/https://carb-x.org/partners/funding-partners/ ↩︎
About CoVIC. Coronavirus Immunotherapy Consortium. Retrieved January 19, 2023, from https://web.archive.org/web/20230119213917/https://covic.lji.org/about/ ↩︎